2020

07 May 2020

Cetilar® obtains Play Sure Doping Free certification and PharmaNutra launches a new advertising campaign

The No Doping Life association assigns the Play Sure Doping Free stamp to Cetilar® and ApportAL® products, and the company […]

07 May 2020

CETILAR® OBTAINS PLAY SURE DOPING FREE CERTIFICATION

29 April 2020

Four new distribution agreements in EU, Asia and Latin America

Despite the COVID-19 emergency, the PharmaNutra Group is still strengthening its international presence through new trade agreements signed in Romania, […]

29 April 2020

PHARMANUTRA S.P.A.:NEW DISTRIBUTION AGREEMENTS IN EUROPE, ASIA AND LATIN AMERICA.

27 April 2020

PHARMANUTRA S.P.A.: ORDINARY SHAREHOLDERS’ MEETING OF 27th APRIL 2020

17 April 2020

151 Miglia – Trofeo Cetilar postponed to 2021

The Regatta Organising Committee has officially announced the cancellation due to the health emergency. The sporting event is postponed until […]

16 April 2020

Proposte per la nomina del CdA

16 April 2020

PRESENTATION OF PROPOSALS FOR APPOINTMENTS TO THE BOARD OF DIRECTORS OF PHARMANUTRA S.P.A.

15 April 2020

Pfizer invests in PharmaNutra’s Sucrosomial® Technology

The innovative Sucrosomial® Magnesium developed by the PharmaNutra Group is one of the main ingredients of the new Multicentrum MyMAG […]

15 April 2020

PHARMANUTRA S.P.A.: PFIZER INVESTS IN SUCROSOMIAL® TECHNOLOGY

10 April 2020

Relazione del collegio sindacale

10 April 2020

Financial statements 31/12/2019 auditor’s report

10 April 2020

Consolidated financial statements 31/12/19 Auditor’s report

10 April 2020

MODULO DI DELEGA/SUBDELEGA AL RAPPRESENTANTE DESIGNATO EX ART 135 UNDECIES D. LGS. 58/1998

10 April 2020

MODULO DI DELEGA AL RAPPRESENTANTE DESIGNATO EX ART 135 NOVIES D. LGS. 58/1998

10 April 2020

Relazione illustrativa acquisto azioni proprie PharmaNutra

10 April 2020

Relazione illustrativa bilancio 2019

10 April 2020

RELAZIONE ILLUSTRATIVA NOMINA CdA

09 April 2020

NOTICE OF CALL FOR ORDINARY SHAREHOLDERS’ MEETING

09 April 2020

PHARMANUTRA S.P.A.: NOTICE OF CALL FOR ORDINARY SHAREHOLDERS’ MEETING

06 April 2020

PHARMANUTRA S.P.A.: PROPOSAL TO AUTHORISE THE PURCHASE AND DISPOSAL OF TREASURY STOCK